Clinical trial · Observational
Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal Cancer
NCT03066167CI-TRIAL-00046242completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study validates 3 well known dysphagia scores for dysphagia due to malignancies of the oesophagus and gastro-oesophageal junction and to the Swedish language.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dysphagia, Esophageal | — | UNRESOLVED | — |
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Validation of different dysphagia scores | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients
- description
- Patients with oesophageal cancer and dysphagia
- interventionNames
- Other: Validation of different dysphagia scores
- label
- Controls
- description
- Healthy Controls with no known dysphagia
- interventionNames
- Other: Validation of different dysphagia scores
Primary outcomes (2)
- measure
- Validation of dysphagia scores
- timeFrame
- 10-14 days
- measure
- Translation of scores to the Swedish language
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Cancer in the gastro-esophageal junction or in the esophagus * Dysphagia * Ability to fill in the questionnaires * Written acceptance of the informed consent Exclusion Criteria: * Not for-filling inclusion criteria * No consent
References
Publications (0)
Data not yet available
No reference posted for this study.